cromolyn sodium has been researched along with Pelvic Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engel, G; Murphy, SF; Osborn, CV; Pattabiraman, G; Schaeffer, AJ; Thumbikat, P | 1 |
| Bradley, C; Kreder, K; Liu, L; Liu, W; Luo, Y; Lutgendorf, S; O'Donnell, M; Schrepf, A; Wang, X | 1 |
2 other study(ies) available for cromolyn sodium and Pelvic Pain
| Article | Year |
|---|---|
Efficacy of Targeted Mast Cell Inhibition Therapy in Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Topics: Chronic Disease; Chronic Pain; Cromolyn Sodium; Humans; Male; Mast Cells; Pelvic Pain; Prostatitis; Quality of Life; RNA, Messenger; Th17 Cells; Tryptases | 2023 |
Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
Topics: Animals; Autoimmune Diseases; Behavior, Animal; CD8-Positive T-Lymphocytes; Cells, Cultured; Cromolyn Sodium; Cystitis, Interstitial; Cytokines; Disease Models, Animal; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ovalbumin; Pelvic Pain; Proto-Oncogene Proteins c-kit; RNA, Messenger; Urinary Bladder | 2016 |